North America Brain Monitoring Market Outlook 2025-2035
The North America Brain Monitoring Market is experiencing robust growth, fueled by technological advancements and increasing neurological disorders across the region. Innovative solutions such as portable EEGs and AI-driven diagnostic software are accelerating adoption in clinical and research settings. Rising awareness, improved reimbursement policies, and a surge in sleep and neurodegenerative diseases are broadened applications of both invasive and non-invasive monitoring systems. The growing geriatric population and demand for real-time patient data further stimulate market expansion, while collaborations and strategic investments by leading players enhance product portfolios and regional penetration.
Latest Market Dynamics
Key Drivers
Rising prevalence of neurological disorders such as epilepsy, Alzheimer’s, and Parkinson’s disease, leading to increased adoption of advanced brain monitoring technologies. For example, Medtronic
launched new minimally invasive EEG systems in early 2025, streamlining patient diagnosis.
Increasing demand for non-invasive and portable brain monitoring equipment to support home-based and ambulatory care. Philips Healthcare recently introduced its latest portable EEG device, facilitating real-time monitoring outside the clinical environment.
Key Trends
Integration of artificial intelligence and machine learning for improved diagnostic accuracy and predictive analytics. Siemens Healthineers implemented AI-powered EEG analytics in their BrainWave platform in 2025, enhancing early detection capabilities.
Rising investments and partnerships in R&D initiatives to develop next-generation brain monitoring solutions. In June 2024, Natus Medical Incorporated partnered with leading neurology clinics in the US to advance remote brain monitoring systems.
Key Opportunities
Expansion into untapped ambulatory and remote patient monitoring markets due to growing demand for telemedicine solutions. Advanced Brain Monitoring, Inc. expanded its remote EEG services, increasing access for rural and underserved populations in 2025.
Development of wearable and cloud-integrated monitoring systems, allowing seamless data sharing between healthcare professionals. Masimo Corporation announced a new cloud-based continuous EEG monitoring device in July 2024.
Key Challenges
Interoperability issues across various brain monitoring devices and hospital EMR systems, which can limit data integration and workflow efficiency. Natus Medical faced operational delays in integrating new EEG systems with hospital IT in early 2025.
High initial investment costs and reimbursement uncertainties for advanced monitoring equipment. Smaller clinics reported cost-related barriers in adopting GE Healthcare’s latest Magnetoencephalography systems in 2025.
Key Restraints
Stringent regulatory requirements and approval processes, particularly for implants and invasive devices. FDA’s elongated approval timeline delayed Philips Healthcare’s new intracranial monitoring device in 2024.
Patient data privacy and cybersecurity issues related to connected brain monitoring solutions. Compumedics Limited enhanced its data encryption protocols after cybersecurity incidents in Q3 2024.
North America Brain Monitoring Market Share (%) by Type, 2025
In 2025, devices dominate the North America Brain Monitoring Market, accounting for 48% of the total share due to the increased adoption of advanced hardware such as EEG, MEG, and ICP monitors. Software solutions, comprising 28% of the market, are rapidly growing as healthcare providers focus on data analytics and AI-assisted diagnostics. Services contribute 24%, reflecting the growing demand for ongoing monitoring, support, and maintenance. The focus on real-time data, accuracy, and integration of hardware with software and service support models is driving holistic market development, enabling comprehensive brain health management.
North America Brain Monitoring Market Share (%) by Applications, 2025
Traumatic Brain Injury (TBI) leads the market share for brain monitoring applications in North America, comprising 32% in 2025. Stroke applications account for 27%, driven by rising incidences and innovative acute monitoring solutions. Dementia follows with 18%, as early detection tools gain importance due to the aging population. Epilepsy and sleep disorders represent 13% and 10% respectively, supported by robust clinical utility of EEG and portable devices. The broad application range highlights the essential role of brain monitoring technologies in both acute and chronic neurological care management.
North America Brain Monitoring Market Revenue (USD Million), 2020-2035
The North America Brain Monitoring Market is projected to grow steadily from $1,890 Million in 2021 to $5,170 Million by 2035. This growth trajectory is underpinned by advances in technology, increasing prevalence of neurological disorders, and greater acceptance of ambulatory and home-based monitoring. The adoption of AI-enhanced and interoperable devices is expected to sustain high single-digit CAGR over the forecast period. U.S. retains market leadership, with Canada and Mexico contributing to regional expansion through government initiatives and private sector investments.
North America Brain Monitoring Market YoY Growth (%), 2020-2035
The year-over-year growth rate for the North America Brain Monitoring Market peaks at 8.1% in 2025, gradually moderating to around 7.5% by 2030 and 6.2% by 2035 as the market matures and adoption saturates in key segments. This dynamic reflects the influx of innovation and new market entrants, which drives early acceleration, followed by steady expansion as technology penetration increases and new application areas open up. Sustained investment and clinical adoption ensure resilient market dynamics throughout the forecast period.
North America Brain Monitoring Market Share (%) by Region, 2025
The United States commands the largest share of the North America Brain Monitoring Market in 2025 at 71%, driven by significant healthcare investments, advanced hospital infrastructure, and favorable regulatory policies for neurotechnology adoption. Canada holds a 18% share, bolstered by rising neurological cases and public health initiatives. Mexico constitutes 11%, reflecting ongoing improvements in healthcare access and rapid growth in private neurodiagnostic services. These regional dynamics demonstrate robust overall market potential and highlight key national priorities and capabilities.
North America Brain Monitoring Market Share (%) by Players, 2025
Medtronic leads the competitive landscape with a 19% market share in 2025, owing to its comprehensive product offerings and focus on both invasive and non-invasive monitoring solutions. Natus Medical follows with 14%, supported by its strong presence in EEG and neurodiagnostic services. Siemens Healthineers, with a 12% share, benefits from robust R&D and advanced imaging integration. The rest of the market is populated by key innovators such as GE Healthcare, Philips, and emerging players specializing in AI and remote monitoring technologies.
North America Brain Monitoring Market Share (%) by Buyers, 2025
Hospitals are the primary buyers in the North America Brain Monitoring Market, accounting for 54% due to the need for comprehensive neurodiagnostic and critical care capabilities. Diagnostic centers make up 22%, leveraging advanced equipment for outpatient and specialist services. Ambulatory surgical centers are gaining pace and represent 14% of demand, driven by minimally invasive and rapid turnaround monitoring needs. Clinics and other buyers account for the remainder, contributing to the broad deployment of both portable and integrated brain monitoring solutions.
June 2024: Natus Medical announced a new partnership with Mayo Clinic for the development of next-gen ambulatory EEG technology.
July 2024: Masimo Corporation launched a cloud-integrated continuous EEG monitoring device aimed at outpatient and telehealth expansion.
August 2024: GE Healthcare released its updated MEG systems with improved accuracy and interoperability for large neurology centers.
September 2024: Medtronic obtained FDA approval for its portable, non-invasive epilepsy monitoring system for home use.
October 2024: Compumedics Limited enhanced its cybersecurity protocols for cloud-connected neurodiagnostic platforms in North America.
Frequently Asked Questions
About the Author
Clara
Senior Market Research Analyst
Clara is a Senior Market Research Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Clara brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Clara has helped organizations translate data into actionable growth strategies.
